Key evidence includes: Gastric emptying studies (also called gastric scintigraphy) showing delayed stomach emptying, which is the gold standard test for diagnosing gastroparesis Medical records documenting your GLP-1 prescription, dosage, duration of use, and the timeline of when symptoms began Emergency room records if you sought treatment for severe nausea, vomiting, dehydration, or intestinal blockage Hospitalization records, if you required inpatient treatment for GI complications Diagnostic imaging, such as upper GI series, CT scans, or MRIs, showing intestinal problems Endoscopy or colonoscopy results, if performed to evaluate your symptoms Pharmacy records showing when you filled prescriptions and how long you used the medication Documentation of treatments, including medications for nausea, dietary changes, or surgical interventions If you experienced severe symptoms consistent with gastroparesis but havent undergone gastric emptying studies, talk to your healthcare provider about appropriate testing

Both these programs only cover Ozempic for certain populations, like seniors
612 A phase 2 study showed that VX-150 could reduce pain scores caused by SFN
Further qualitative research could help to investigate about the potential factors underlying the relationship between autistic traits as measured by the AQ and GD
MT-2, on the other hand, affects a broader range of receptors, producing quicker and more intense tanning, while also having effects on appetite, metabolism, and sexual function